InsidersTradesSigma
Follow the IMMURON LIMITED stock price and the full management transaction log of the company, a listed issuer based in Australia. Shares trade on the AU market, under the oversight of ASX. Market capitalisation: €8.6m. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
IMMURON LIMITED is a company listed on the XASX, focused on developing treatments for intestinal health-related diseases. It emphasizes research and innovation in the pharmaceutical sector.